Diagnostics Pipeline: 2024 Trends in FDA Approvals
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
Keeps You Up-to-Date on New Diagnostic Tests, Testing Trends and Opportunities, and Emerging Test Technologies
In vitro diagnostic products approved by the U.S. Food and Drug Administration in 2024 show a continued move toward rapid and point-of-care tests
From - Diagnostic Testing & Emerging Technologies
Like all other industries, the laboratory industry will feel the effects of the digital revolution. In some cases, digital technology will make operations more efficient and cut human errors by…
From - Diagnostic Testing & Emerging Technologies
Mass spectrometry (MS) is rapidly transitioning from specialized clinical testing—drugs of abuse confirmations, newborn screening, and steroid analysis—to being broadly applied throughout…
From - Diagnostic Testing & Emerging Technologies
Diagnosing Zika virus is challenging. While diagnosis previously relied on serology, it is difficult to differentiate Zika antibodies from other closely related viruses…